SCHRöDINGER
Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990, has over 700 employees and is engaged with customers and collaborators in more than 70 countries. To learn more visit www.schrodinger.com.
SCHRöDINGER
Industry:
Biotechnology Enterprise Software Pharmaceutical Software
Founded:
1990-08-16
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.schrodinger.com
Total Employee:
501+
Status:
Active
Contact:
1 503 299 1150
Total Funding:
567.22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving Apache
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Dls Solutions Inc
DLS Solutions develops custom software for analytical and biotechnology instrumentation.
MolecularWare
MolecularWare develops data management software for high throughput biology.
Reify
Reify develops and markets machine vision and video analysis software-based phenotypic screens for the biotechnology industries.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-01-18 | Xtal BioStructures | Xtal BioStructures acquired by Schrödinger | 6 M USD |
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Schrödinger
Pavilion Capital
Pavilion Capital investment in Series E - Schrödinger
Michael Antonov
Michael Antonov investment in Series E - Schrödinger
Invus
Invus investment in Series E - Schrödinger
Laurion Capital Management
Laurion Capital Management investment in Series E - Schrödinger
Sixty Degree Capital
Sixty Degree Capital investment in Series E - Schrödinger
Formic Ventures
Formic Ventures investment in Venture Round - Schrödinger
GV
GV investment in Series E - Schrödinger
WuXi AppTec
WuXi AppTec investment in Series E - Schrödinger
Deerfield
Deerfield investment in Series E - Schrödinger
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-20 | ShouTi | Schrödinger investment in Series B - ShouTi | 100 M USD |
| 2021-06-01 | Ajax Therapeutics | Schrödinger investment in Venture Round - Ajax Therapeutics | 40 M USD |
| 2019-12-03 | Bright Angel Therapeutics | Schrödinger investment in Seed Round - Bright Angel Therapeutics | N/A |
| 2018-09-25 | Morphic Therapeutic | Schrödinger investment in Series B - Morphic Therapeutic | 80 M USD |
| 2018-06-05 | Nimbus Therapeutics | Schrödinger investment in Series C - Nimbus Therapeutics | 65 M USD |
| 2016-06-30 | Morphic Therapeutic | Schrödinger investment in Series A - Morphic Therapeutic | 51.5 M USD |
| 2016-01-01 | Morphic Therapeutic | Schrödinger investment in Seed Round - Morphic Therapeutic | 3 M USD |
| 2010-04-29 | Nimbus Therapeutics | Schrödinger investment in Seed Round - Nimbus Therapeutics | 3.5 M USD |
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-18 | Schrödinger Appoints Geoffrey Porges as Chief Financial Officer |
Official Site Inspections
http://www.schrodinger.com Semrush global rank: 338.39 K Semrush visits lastest month: 178.24 K
- Host name: 192.0.66.218
- IP address: 192.0.66.218
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
More informations about "Schrödinger"
About us - Schrödinger
We are driven to be the world leader in transforming drug discovery and materials design by relentlessly pursuing scientific and technology breakthroughs.; We are committed to achieving the best possible outcomes for our customers, …See details»
Schrödinger - Physics-based Software Platform for …
Advancing a pipeline of therapeutics built from our platform. Schrödinger’s therapeutics group strives to reduce risk in drug discovery and development by selecting high-value targets with established human genetics or clinical …See details»
Schrödinger, Inc. - Wikipedia
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science. Schrödinger's software is used by pharmaceutical companies, biotech firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerat…See details»
Schrödinger - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 1 503 299 1150 Schrödinger develops a computational platform that facilitates the research efforts of biopharmaceutical and industrial …See details»
Schrödinger - The Org
Schrödinger, LLC is an American software company that develops chemical simulation software for use in pharmaceutical, biotechnology, and materials science research.See details»
Governance - Documents & Charters - Schrödinger, Inc.
Ombuds Office for Schrödinger Europe. As a global company with operations in Europe, we also offer reporting through an Ombuds Office (or an Ombudslawyer) for Schrödinger GmbH and …See details»
Schrodinger, Inc. - AnnualReports.com
Schrodinger, Inc. reports have an aggregate usefulness score of 4.7 based on 162 reviews. Schrodinger, Inc. Most Recent Annual Report. MOST RECENT 2023 Annual Report and Form …See details»
Defining Moments in Schrödinger’s History
About our company. At Schrödinger, you’ll be part of a global team of more than 800 individuals dedicated to improving the health and quality of human life, armed with the knowledge that …See details»
Governance - Committee Composition - Schrödinger, Inc.
[email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your …See details»
Schrödinger, Inc. - Investor Relations
Nov 18, 2024 [email protected]. Investor Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After …See details»
Schrodinger Inc - MassBio
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, …See details»
Schrödinger - LinkedIn
Schrödinger's Shaoxian Sun recently presented new preclinical data on SGR-3515, our investigational Wee1/Myt1 inhibitor, during a poster session at the 36th EORTC-NCI-AACR …See details»
Our Team - Schrödinger
Proprietary Pipeline Highlights. SGR-1505 (MALT1) SGR-1505 is a mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitor. SGR-2921 (CDC7) SGR-2921 is a …See details»
Schrödinger Provides Update on Progress Across the Business and ...
Jan 9, 2023 Founded in 1990, Schrödinger has approximately 800 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit …See details»
Corporate Sustainability - Schrödinger
As part of a suite of benefits, employees who work at least 25 hours per week are provided a paid day off each year to volunteer with an organization or program of their choice. Additionally, …See details»
Schrödinger, Inc. - Schrödinger Announces Multi-Target …
Nov 12, 2024 Schrödinger to receive $150 million upfront and eligible to receive up to approximately $2.3 billion in milestone payments plus royalties Expanded multi-year software …See details»
Why does my Schrödinger Account (website account) verification …
Collaborate with IT: Sharing the email headers with your IT team can pinpoint delays within your organization's email system. Resolution . Adjusting gray-listing or antivirus settings for known …See details»
Schrödinger, Inc. - Schrödinger Reports Strong Fourth Quarter and …
Achieved Fourth Quarter Software Revenue of $68.7 Million, a 44% Increase Over Fourth Quarter 2022 Delivered 20% Annual Total Revenue Growth, with Total Revenue of $216.7 Million …See details»
20 years of Glide: A legacy of docking innovation and the next …
Key Features. Glide WS is a molecular docking workflow built on the foundation of Glide SP 2, 3 and WScore 4 that provides significantly improved sampling and scoring of small molecules in …See details»
All Online Certification Courses - Schrödinger
[email protected]. How can I preview the course before registering? Free Course Preview. Are there any scholarship opportunities available for students? Schrödinger is …See details»